CompoAtlas

Mr. Hyde

Mr. Hyde, licence 80068609: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Pro Supps USA, LLC
NPN or DIN-HM
80068609
Status
Active licence
Licence date
18 April 2016
Revision date
Not provided
Form
Poudre
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
L-Leucine

Source : L-Leucine

500.0 milligrammeNot calculated
Acide bêta-aminopropionique

Source : Beta-alanine

2500.0 milligrammeNot calculated
Glycine, N-(aminoiminométhyl)-N-méthyl-, monohydrochlorure

Source : Chlorhydrate de créatine

1000.0 milligrammeNot calculated
Sulfate de (4-Aminobutyle)guanidinium

Source : Sulfate d'agmatine

500.0 milligrammeNot calculated
Malate de citrulline

Source : Malate de citrulline

500.0 milligrammeNot calculated
1,3,7-triméthylxanthine

Source : Caféine

400.0 milligrammeNot calculated
1,3,7-triméthylxanthine

Source : Citrate de caféine

400.0 milligrammeNot calculated
2-para-hydroxyphényléthylamine

Source : Tyramine

200.0 milligrammeNot calculated
1-(p-Hydroxyphényl)-2-aminoéthanol

Source : Chlorhydrate de DL-Octopamine

12.12 milligrammeNot calculated
Citrus aurantium

Source : Citrus aurantium - Fruit peel

Potency : 30.0 % Synephrine

30.0 milligrammeNot calculated
Acide gamma-aminobutyrique

Source : Acide 4-aminobutanoïque

50.0 milligrammeNot calculated

Non-medicinal ingredients

Acésulfame potassium, Silice, Acide citrique, Rouge FD&C N° 40, Sucralose, Saveur de goyave, Saveur de punch aux fruits, Silicate de calcium, Bleu FD&C n° 1, Saveur de melon d'eau, Jaune FD&C No. 5, Saveur de raisin, Maltodextrines résistantes, Lécithine, Saveur d'orange, Saveur de pomme verte, Saveur de framboise, Saveur de mangue, Saveur de cerise, Saveur de citron, Acide DL-malique

PopulationAgeQuantity per servingFrequency
AdultesNot specified0.5 Mesures1.0 Jour(s)

Uses authorised in Canada

Text supplied in English because no French text is available.

Caffeine helps to relieve fatigue, to promote endurance, and to enhance motor performance. Caffeine helps to promote alertness and wakefulness, and to enhance cognitive performance. Leucine is an essential amino acid involved in protein synthesis. Caffeine helps to temporarily increase basal metabolic rate/thermogenesis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80068609

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line